A new trading day began on Monday, with BriaCell Therapeutics Corp (NASDAQ: BCTX) stock price up 12.99% from the previous day of trading, before settling in for the closing price of $0.98. BCTX’s price has ranged from $0.46 to $5.97 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -46.39%. With a float of $32.50 million, this company’s outstanding shares have now reached $36.18 million.
In terms of profitability, gross margin is 50.0%, operating margin of -146664.88%, and the pretax margin is -21134.78%.
BriaCell Therapeutics Corp (BCTX) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of BriaCell Therapeutics Corp is 10.17%, while institutional ownership is 7.33%. The most recent insider transaction that took place on May 14 ’24, was worth 2,000,001. In this transaction Director of this company bought 902,935 shares at a rate of $2.21, taking the stock ownership to the 2,542,935 shares.
BriaCell Therapeutics Corp (BCTX) Earnings and Forecasts
In its latest quarterly report, released on 7/31/2024, the company reported earnings of 0.36 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -46.39% per share during the next fiscal year.
BriaCell Therapeutics Corp (NASDAQ: BCTX) Trading Performance Indicators
Here are BriaCell Therapeutics Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.49.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.16, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.84 in one year’s time.
Technical Analysis of BriaCell Therapeutics Corp (BCTX)
Analysing the last 5-days average volume posted by the [BriaCell Therapeutics Corp, BCTX], we can find that recorded value of 1.82 million was better than the volume posted last year of 1.58 million. As of the previous 9 days, the stock’s Stochastic %D was 96.82%. Additionally, its Average True Range was 0.10.
During the past 100 days, BriaCell Therapeutics Corp’s (BCTX) raw stochastic average was set at 43.18%, which indicates a significant decrease from 96.52% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 157.30% in the past 14 days, which was higher than the 153.21% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8176, while its 200-day Moving Average is $1.4560. Now, the first resistance to watch is $1.1666. This is followed by the second major resistance level at $1.2232. The third major resistance level sits at $1.3164. If the price goes on to break the first support level at $1.0168, it is likely to go to the next support level at $0.9236. Should the price break the second support level, the third support level stands at $0.8670.
BriaCell Therapeutics Corp (NASDAQ: BCTX) Key Stats
With a market capitalization of 40.16 million, the company has a total of 36,183K Shares Outstanding. Currently, annual sales are 0 K while annual income is -4,790 K. The company’s previous quarter sales were 0 K while its latest quarter income was -1,210 K.
